期刊文献+

过敏性咽喉炎顽固性咳嗽的中药治疗 被引量:5

Traditional Chinese medicine treatment of allergic pharyngitis stubborn cough
原文传递
导出
摘要 目的探讨治疗过敏性咽喉炎顽固性咳嗽的有效药物。方法采用中药方剂(中药12味)治疗过敏性咽喉炎顽固性咳嗽患者,并设置孟鲁司特钠(顺尔宁)对照组,分别治疗3个月并观察其治疗效果;1年后随访观察治疗效果。结果治疗3个月后,中药方剂(中药12味)疗效显著优于孟鲁司特钠(顺尔宁)对照组;咳嗽、哮喘等症状经3个月的治疗后基本消失;1年后随访患者病情稳定,很少复发。结论本药物疗效好、愈后很少复发,可标本兼治,服用方便、简单,安全可靠。 Objective To explore the effective medicine for the treatment of allergic pharyngitis intractable cough.Methods Traditional Chinese medicine(12 kinds of Chinese medicine)was used in the treatment of allergic pharyngitis stubborn cough patients for 3 months,while the montelukast sodium(Shun Er-ning)was set as control group.The therapeutic effects of these two groups were observed after 1 years follow-up.Results After 3 months of treatment,the efficacy of traditional Chinese medicine(12 kinds of traditional Chinese medicine)group was significantly better than montelukast(Shun Er-ning)group.Symptoms of cough and asthma disappeared with little recurrence.Conclusion The curative efficacy of traditional Chinese Medicine was better with little recurrence.It was token conveniently with safety and reliability.
出处 《中国医学文摘(耳鼻咽喉科学)》 2016年第2期68-71,共4页 Chinese Medical Digest(Otorhinolaryngology)
关键词 变态反应 咽喉炎 咳嗽 中药方剂(中药12味) 孟鲁司特钠 Allergic Reaction Pharyngolaryngitis Cough Chinese medicine(12 herbs) Montelukast sodium
  • 相关文献

参考文献4

  • 1Bacharier LB, BonerA, Carlsen K-H, et al. Diagnosis and treatnment of asthma in childhood: a PRACTALL consensus report. Allergy, 2008, 63: 5-34.
  • 2Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ, 2003, 327: 891-895.
  • 3Price DB, Swem A, Tozzi CA, et al. Effect ofmontelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy, 2006, 61: 737-742.
  • 4Virchow JC, Mehta A, Ljungblad L, et al. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. Respir Med, 2010, 104: 644-651.

同被引文献38

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部